Ombow, Concerning that Baker Bros stock, Seattle Genetics (SGEN), I remember them from many years ago (pre Cortex), when I followed a cancer company called Immunogen. SGEN was a competitor, with both companies in the MAB/Monoclonal Antibody area, which was still fairly new back then.
Everyone dissed SGEN at the time, but here they are at 100/share, while IMGN is floundering at 2. That article says the Baker Bros have owned SGEN for over 15 years.
If I ever wanted to get back into bio investing, beyond buying a bio ETF, a viable approach would be to replicate the Baker Bros holdings. This could easily be done, either by creating a custom ETF over at Motif Investing, or by buying small amounts of each stock individually (as little as 1 share of each stock). This approach is feasible thanks to the new zero commission policy at most discount brokers, and it also allows dollar cost averaging of smaller amounts with zero commissions.
You let the proven experts (Baker Bros) do the hard part, picking the stocks, and you tag along for the ride. I can think of a lot worse strategies (and I tried most of them lol)..
